Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing

This document records administrative actions for proposed policy DL36029 (Controlled Substance Monitoring and Drugs of Abuse Testing): it was presented at an open meeting on 2020-10-13, posted for notice 2021-01-21 to 2021-03-07, and became effective 2021-03-08. No comments were received during the open comment period. This document does not contain substantive clinical coverage criteria, limitations, or frequency limits.

"Proposed policy DL36029 (Controlled Substance Monitoring and Drugs of Abuse Testing) was presented at the joint open meeting for Kentucky and Ohio on 2020-10-13."

Sign up to see full coverage criteria, indications, and limitations.